CPHI [CHINA PHARMAS,] 424B3: FORM 8-K CURRENT REPORT August 28, 2009 China

[FORM 8-K CURRENT REPORT August 28, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 ITEM 8.01 Other Events]

By | 2016-02-08T00:08:07+00:00 September 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-A12B: (Original Filing)

[Explanatory Notempanymmon Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharmas, a Delawarerporation (the Item 1.Description of thempanys Securities to be Registeredmmission 1 China Pharmas, I nc . Zhilin Li Chief Executive Officer 2 cph812b092809.htm 1 8-A12B]

By | 2016-02-08T00:09:05+00:00 September 28th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-A12B: Explanatory Notempanymmon Stock Exchange Act This Registration Statement

[Explanatory Notempanymmon Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharmas, a Delawarerporation (the Item 1.Description of thempanys Securities to be Registeredmmission 1 China Pharmas, I nc . Zhilin Li Chief Executive Officer 2 cph812b092809.htm 1 8-A12B]

By | 2016-02-08T00:09:56+00:00 September 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEFR14C: (Original Filing)

[SCHEDULE 14C INFORMATION [ ] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]

By | 2016-02-08T00:10:56+00:00 September 23rd, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEFR14C: SCHEDULE 14C INFORMATION [ ] Preliminary Information Statement

[SCHEDULE 14C INFORMATION [ ] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]

By | 2016-02-08T00:12:09+00:00 September 23rd, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEF 14C: SCHEDULE 14C INFORMATION Amendment No. 1 [X] Preliminary

[SCHEDULE 14C INFORMATION Amendment No. 1 [X] Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction]

By | 2016-02-08T00:13:44+00:00 September 23rd, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] PRE 14C: SCHEDULE 14C INFORMATION Amendment No. 1 X] [

[SCHEDULE 14C INFORMATION Amendment No. 1 X] [ Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which]

By | 2016-02-08T00:15:41+00:00 September 15th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar